L. Patrick Gage, Director at TETRAPHASE PHARMACEUTICALS INC (TTPH), bought 5,000 shares at $9.25 ($46K) on 2014-05-14, disclosed to the SEC on 2014-05-16.
Open-market purchase of $46k TTPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CYTK | SELL | 2021-03-12 | $439K | — | Filing → |
| CYTK | SELL | 2020-12-15 | $162K | — | Filing → |
| CYTK | SELL | 2020-03-20 | $119K | — | Filing → |